首页> 外文期刊>The Journal of Urology >Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.
【24h】

Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.

机译:根治性肾切除术治疗的透明细胞肾细胞癌患者的动态结果预测:D-SSIGN评分。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To date all prediction models for patients with renal cell carcinoma have estimated outcome in static fashion starting from the date of surgery only. We created a dynamic outcome prediction model for continual surveillance that accounts for the disease-free interval following surgery. MATERIALS AND METHODS: We identified 1,560 patients treated with radical nephrectomy for pM0 clear cell renal cell carcinoma between 1970 and 1999. The previously published stage, size, grade and necrosis score was used to stratify patients according to the risk of death from renal cell carcinoma. Cancer specific survival rates were calculated using the Kaplan-Meier method at surgery and at various disease-free intervals following surgery. RESULTS: At last followup 461 of the 1,560 patients had died of renal cell carcinoma at a median of 3.1 years following surgery. Median followup in patients still alive was 11.2 years. Patient outcome improved as the disease-free interval following surgery increased. For example, patients with a stage, size, grade and necrosis score of 5 had an estimated 5-year cancer specific survival rate of 69.6% at surgery. However, those who survived without disease for 1, 2 and 3 years following surgery had adjusted estimated 5-year cancer specific survival rates of 81.9%, 91.9% and 93.2%, respectively. Patients with a stage, size, grade and necrosis score of 7 had a 5-year cancer specific survival rate of 44.9% at surgery, which increased to 63.3%, 71.0% and 72.8% after 1 to 3 years of disease-free followup, respectively. CONCLUSIONS: Within each stage, size, grade and necrosis score cancer specific survival rates increase as the disease-free interval following surgery increases. We present a dynamic outcome prediction model that allows clinicians to continually adjust surveillance as the disease-free interval increases.
机译:目的:迄今为止,所有肾细胞癌患者的预测模型均仅从手术之日起就以静态方式估计了结果。我们创建了用于持续监测的动态结果预测模型,该模型可说明手术后的无病间隔。材料与方法:我们确定了1970年至1999年间1,560例接受过彻底根治性肾切除术治疗的pM0透明细胞肾细胞癌的患者。根据肾细胞癌的死亡风险,使用先前发表的分期,大小,等级和坏死评分对患者进行分层。使用Kaplan-Meier方法在手术时以及手术后各个无病间隔计算癌症特异性生存率。结果:在最后一次随访中,在1,560名患者中,有461名在手术后中位3.1年死于肾细胞癌。存活患者的中位随访时间为11.2年。随着手术后无病间隔时间的延长,患者的预后得到改善。例如,分期,大小,等级和坏死评分为5的患者在手术中的5年癌症特异性生存率估计为69.6%。然而,那些在手术后1、2和3年无病生存的人将估计的5年癌症特异性生存率分别调整为81.9%,91.9%和93.2%。分期,大小,等级和坏死评分为7的患者在手术中的5年癌症特异性生存率为44.9%,在进行1至3年的无病随访后,其五年生存率分别提高到63.3%,71.0%和72.8%,分别。结论:在每个阶段,随着手术后无病间隔时间的延长,癌症的特异性存活率也随之增加。我们提出了一个动态的结果预测模型,该模型允许临床医生随着无病间隔的增加而不断调整监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号